Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia AML”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00947648
What this trial is testing

Outpatient Neutropenic Diet Study

Who this might be right for
LeukemiaNeutropenia
M.D. Anderson Cancer Center 30
Not applicableStudy completedNCT07155382
What this trial is testing

Allogeneic HCT Using Conditioning Regimen of BuFluATG for AML CR1

Who this might be right for
Acute Myeloid Leukemia (AML)
Asan Medical Center 98
Testing effectiveness (Phase 2)Study completedNCT00548847
What this trial is testing

Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

Who this might be right for
Leukemia
Emory University 15
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Testing effectiveness (Phase 2)Study completedNCT02296242
What this trial is testing

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndrome
BioMed Valley Discoveries, Inc 53
Not applicableUnknownNCT00502983
What this trial is testing

Molecular Epidemiology of Acute Myelogenous Leukemia

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 519
Testing effectiveness (Phase 2)Ended earlyNCT04849910
What this trial is testing

Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS

Who this might be right for
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Vor Biopharma 67
Large-scale testing (Phase 3)Study completedNCT00703820
What this trial is testing

Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
St. Jude Children's Research Hospital 324
Early research (Phase 1)Study completedNCT01662505
What this trial is testing

Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Looking for participantsNCT04501120
What this trial is testing

Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML

Who this might be right for
Relapsed/Refractory Acute Myeloid LeukaemiaMyeloid Malignancy
Ascentage Pharma Group Inc. 682
Testing effectiveness (Phase 2)Looking for participantsNCT07025824
What this trial is testing

Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation

Who this might be right for
AML - Acute Myeloid LeukemiaMDS (Myelodysplastic Syndrome)
Technische Universität Dresden 220
Not applicableStudy completedNCT02867891
What this trial is testing

Sorafenib In Relapse of FMS-like Tyrosine Kinase 3 (FLT3)-Internal Tandem Duplication (ITD) AML Trial

Who this might be right for
Acute Myeloid Leukemia
Robert Zeiser 396
Large-scale testing (Phase 3)Looking for participantsNCT05939180
What this trial is testing

VA vs DA for Newly Diagnosed Hig-risk AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 116
Early research (Phase 1)Study completedNCT00098423
What this trial is testing

Tanespimycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic Leukemia+23 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00346359
What this trial is testing

Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Looking for participantsNCT02416388
What this trial is testing

Study to Improve OS in 18 to 60 Year-old Patients, Comparing Daunorubicin Versus High Dose Idarubicin Induction Regimens, High Dose Versus Intermediate Dose Cytarabine Consolidation Regimens, and Standard Versus MMF Prophylaxis of GvHD in Allografted Patients in First CR

Who this might be right for
Acute Myeloid Leukemia (AML)
University Hospital, Angers 3,100
Early research (Phase 1)Study completedNCT01019161
What this trial is testing

An Open Label, Single Centre Mass Balance C14 Study in Patients With Acute Myeloid Leukaemia (AML)

Who this might be right for
Acute Myeloid Leukaemia
AstraZeneca 5
Early research (Phase 1)WithdrawnNCT05823480
What this trial is testing

Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center
Not applicableLooking for participantsNCT07080970
What this trial is testing

Observational Study on APL-like aCute Myeloid Leukemia: disTInct Phenotype and Early VAscular complicaTions

Who this might be right for
Acute Myeloid LeukemiaNPM1 Mutation
Gruppo Italiano Malattie EMatologiche dell'Adulto 220
Not applicableStudy completedNCT02861651
What this trial is testing

Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 40
Next Page